Related references
Note: Only part of the references are listed.Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution
Sandra H. E. Boots-Sprenger et al.
MODERN PATHOLOGY (2013)
Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age
Daniela Loetsch et al.
NEURO-ONCOLOGY (2013)
Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images
Kourosh M. Naeini et al.
NEURO-ONCOLOGY (2013)
Volumetric and MGMT parameters in glioblastoma patients: Survival analysis
Georgios Iliadis et al.
BMC CANCER (2012)
A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene Signature
Pascal O. Zinn et al.
PLOS ONE (2012)
A critical evaluation of cystic features in primary glioblastoma as a prognostic factor for survival Clinical article
Gurvinder Kaur et al.
JOURNAL OF NEUROSURGERY (2011)
Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab
Benjamin M. Ellingson et al.
NEURO-ONCOLOGY (2011)
Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI
B. Hakyemez et al.
CLINICAL RADIOLOGY (2010)
Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme
John K. Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme Clinical article
Kaisorn Chaichana et al.
JOURNAL OF NEUROSURGERY (2010)
Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology
Richard Simon
PERSONALIZED MEDICINE (2010)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
The Importance of Tumor Volume in the Prognosis of Patients with Glioblastoma Comparison of Computerized Volumetry and Geometric Models
Georgios Iliadis et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2009)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Relationship between survival and edema in malignant gliomas: Role of vascular endothelial growth factor and neuronal pentraxin 2
Marc R. J. Carlson et al.
CLINICAL CANCER RESEARCH (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project
ER Laws et al.
JOURNAL OF NEUROSURGERY (2003)
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
M Lacroix et al.
JOURNAL OF NEUROSURGERY (2001)
Share Paper
